Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vext Science Inc. C.VEXT

Alternate Symbol(s):  VEXTF

Vext Science, Inc. is a cannabis operator. The Company’s expertise spans from cultivation through to retail operations in markets of Arizona and Ohio. It manufactures THC cartridges, concentrates, edibles and accessories under the Vapen brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD and Herbal Wellness brands. It has THC concentrates, edibles, and... see more

CSE:VEXT - Post Discussion

Vext Science Inc. > Solid day
View:
Post by Dunworkin2 on Apr 22, 2021 4:59pm

Solid day

Big volume, guessing that the latest financials convinced someone to jump in or add more to their holdings. BC2 is a holder of Vext.
Comment by FunGuy88 on Apr 22, 2021 5:21pm
BC2? ...do you mean CB2?
Comment by Dunworkin2 on Apr 22, 2021 8:45pm
Bruce Campbell from Stonecastle Investments are showing that Vext is 1.7% of their Cdn Equity portfolio.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities